Min Yang

7.1k total citations · 1 hit paper
230 papers, 5.7k citations indexed

About

Min Yang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Min Yang has authored 230 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 64 papers in Oncology and 42 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Min Yang's work include Radiopharmaceutical Chemistry and Applications (29 papers), Peptidase Inhibition and Analysis (23 papers) and Nanoplatforms for cancer theranostics (22 papers). Min Yang is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (29 papers), Peptidase Inhibition and Analysis (23 papers) and Nanoplatforms for cancer theranostics (22 papers). Min Yang collaborates with scholars based in China, United States and Fiji. Min Yang's co-authors include Junjie Yan, Donghui Pan, Xinyu Wang, Xiaohong Chen, Yuping Xu, Zhen Gu, Yue Lü, Quli Fan, Guojun Chen and Zhen Cheng and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Advanced Materials.

In The Last Decade

Min Yang

219 papers receiving 5.7k citations

Hit Papers

Advances in liquid metals for biomedical applications 2018 2026 2020 2023 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Yang China 35 1.9k 1.4k 1.3k 873 836 230 5.7k
Ying Chen China 43 2.4k 1.3× 1.4k 1.0× 1.9k 1.5× 464 0.5× 574 0.7× 148 5.5k
Christoph E. Hagemeyer Australia 41 1.4k 0.8× 1.4k 1.0× 810 0.6× 580 0.7× 1.1k 1.3× 128 5.4k
Chi‐Shiun Chiang Taiwan 44 2.6k 1.4× 1.8k 1.3× 1.6k 1.2× 1.0k 1.2× 800 1.0× 159 7.0k
Yi Hou China 35 2.4k 1.3× 1.4k 1.0× 2.1k 1.6× 321 0.4× 1.2k 1.5× 154 5.0k
Zhibo Liu China 43 1.2k 0.6× 1.9k 1.3× 1.2k 1.0× 1.4k 1.6× 356 0.4× 179 6.7k
Brigitte Gillet France 30 1.4k 0.7× 1.4k 1.0× 2.2k 1.7× 400 0.5× 856 1.0× 91 6.8k
Yin Zhang China 40 1.6k 0.8× 2.5k 1.7× 1.0k 0.8× 454 0.5× 700 0.8× 167 6.1k
Chunmeng Shi China 39 2.9k 1.5× 2.2k 1.5× 1.8k 1.4× 434 0.5× 1.0k 1.2× 188 7.1k
Jun Zhao China 44 1.1k 0.6× 1.7k 1.2× 1.4k 1.1× 394 0.5× 409 0.5× 256 6.4k
Donghui Pan China 34 1.1k 0.6× 704 0.5× 828 0.6× 485 0.6× 443 0.5× 129 3.9k

Countries citing papers authored by Min Yang

Since Specialization
Citations

This map shows the geographic impact of Min Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Yang more than expected).

Fields of papers citing papers by Min Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Yang. The network helps show where Min Yang may publish in the future.

Co-authorship network of co-authors of Min Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Min Yang. A scholar is included among the top collaborators of Min Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Yang. Min Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Donghui, Junjie Yan, Lizhen Wang, et al.. (2025). Development of Novel Peptide-Based Radiotracers for Detecting FGL1 Expression in Tumors. Molecular Pharmaceutics. 22(3). 1605–1614.
2.
C, Liu, Donghui Pan, Yuyun Sun, et al.. (2025). The role of dual-tracer PET imaging with ER and HER2 in patients with metastatic breast cancer: a pilot study. Annals of Nuclear Medicine. 39(10). 1113–1123. 1 indexed citations
3.
Yang, Yong, Ruiyun Chen, Min Yang, et al.. (2025). Impact of Hexagonal Boron Nitride Encapsulation on the Photophysical Dynamics of MAPbI3 Perovskite Crystals. The Journal of Physical Chemistry Letters. 16(12). 2972–2980. 1 indexed citations
4.
Zhang, Yingzhen, Juan Liu, Jun Xiao, et al.. (2024). A PET based colorimetric/fluorescent dual-signal probe for selective detection of hypochlorite in real water samples. Journal of Molecular Structure. 1322. 140568–140568. 5 indexed citations
5.
Wang, Lizhen, Junjie Yan, Yuping Xu, et al.. (2024). Evaluation of chicken chorioallantoic membrane model for tumor imaging and drug development: Promising findings. SHILAP Revista de lepidopterología. 8(2). 287–294. 1 indexed citations
6.
Ding, Xiang, Donghui Pan, Ce Wang, et al.. (2024). Synthesis and Characterization of a Novel PET Tracer for Noninvasive Evaluation of FGL1 Status in Tumors. Molecular Pharmaceutics. 21(7). 3425–3433. 2 indexed citations
7.
Wang, Xinyu, Xiang Ding, Xin Ji, et al.. (2024). Repurposing iron chelators for accurate positron emission tomography imaging tracking of radiometal‐labeled cell transplants. SHILAP Revista de lepidopterología. 5(2). e473–e473. 8 indexed citations
8.
Ji, Xin, Lizhen Wang, Yong Zhong, et al.. (2024). Impact of mesenchymal stem cell size and adhesion modulation on in vivo distribution: insights from quantitative PET imaging. Stem Cell Research & Therapy. 15(1). 456–456.
9.
Jin, Jie, Miao Liu, Liping Mao, et al.. (2023). Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax Plus 3+7 Chemotherapy in Acute Myeloid Leukemia. Advanced Science. 11(11). e2305885–e2305885. 3 indexed citations
11.
Wang, Zixin, Wenjin Zhou, Min Yang, et al.. (2023). The Geometry of Nanoparticle-on-Mirror Plasmonic Nanocavities Impacts Surface-Enhanced Raman Scattering Backgrounds. Nanomaterials. 14(1). 53–53. 1 indexed citations
12.
Li, Shaoqing, Min Yang, Yuanling Zhang, et al.. (2022). A novel fluorescent “OFF-ON” sensing strategy for Hg (II) in water based on functionalized gold nanoparticles. Chemosphere. 303(Pt 2). 135174–135174. 20 indexed citations
13.
Yang, Min, et al.. (2022). The heterogeneity effect of surveillance intervals on progression free survival. Journal of Applied Statistics. 51(4). 646–663. 1 indexed citations
14.
Yang, Min, et al.. (2022). Identification of key target genes and pathway analysis in nonalcoholic fatty liver disease via integrated bioinformatics analysis. SHILAP Revista de lepidopterología. 25(1). 25–34. 4 indexed citations
15.
Jiang, Nan, Xiaolin Ge, Zhao‐Yue Zhang, et al.. (2021). Prognostic Factors for Patients with Esophageal Cancer Receiving Definitive Radiotherapy Alone: A Retrospective Analysis. Cancer Management and Research. Volume 13. 3229–3234. 7 indexed citations
16.
Liu, Jian‐Guo, et al.. (2020). Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137. SHILAP Revista de lepidopterología. 9 indexed citations
17.
Wang, Zhenfan, et al.. (2017). Filamin A (FLNA) regulates autophagy of bladder carcinoma cell and affects its proliferation, invasion and metastasis. International Urology and Nephrology. 50(2). 263–273. 15 indexed citations
18.
Yang, Min, et al.. (2013). Preparation and biodistribution of 99Tcm-PIDP as bone imaging agent. 《核技术》(英文版). 20(5). 1 indexed citations
19.
Sun, Xilin, Gang Niu, Yongjun Yan, et al.. (2010). Phage Display–Derived Peptides for Osteosarcoma Imaging. Clinical Cancer Research. 16(16). 4268–4277. 34 indexed citations
20.
Yang, Min, et al.. (2006). Effect of ganglioside on expression of synaptophysin p38 in rats after cerebral ischemic reperfusion. 10(22). 87–89. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026